Development and validation of a reverse phase liquid chromatography method for the quantification of rasagiline mesylate in biodegradable PLGA microspheres

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 5, 2009, Pages 1185-1191

  Fernández, Marcos ^a,b   Barcia, Emilia ^a   Negro, Sofía ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

HPLC; Microspheres; PLGA; Rasagiline mesylate; Validation

Indexed keywords

MICROSPHERE; RASAGILINE;

ACCURACY; ARTICLE; BIODEGRADABILITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; MICROENCAPSULATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

BIODEGRADATION, ENVIRONMENTAL; CALIBRATION; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; INDANS; LACTIC ACID; MICROSPHERES; MOLECULAR STRUCTURE; MONOAMINE OXIDASE INHIBITORS; PHARMACOPOEIAS AS TOPIC; POLYGLYCOLIC ACID; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE; TIME FACTORS;

EID: 67349261949     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.02.031     Document Type: Article

References (21)

1. LeWitt P.A., and Taylor D.C. Neurotherapy 5 (2008) 210-225
2. Fernández H.H., and Chen J.J. Pharmacotherapy 27 (2007) 1745-1855
3. Guay D. Am. J. Geriat. Pharmacother. 4 (2006) 330-346
4. Chen J.J. Formulary 41 (2006) 18-24
5. Chen J.J. J. Clin. Pharmacol. 45 (2005) 878-894
6. Bar-Am O., Yogev-Falach M., Amit T., Sagi Y., and Youdim M. J. Neurochem. 89 (2004) 1119-1125
7. Bar Am O., Amit T., and Youdim M. Neurosci. Lett. 355 (2004) 169-172
8. Stefanova N., Poewe W., and Wenning G. Exp. Neurol. 210 (2008) 421-427
9. Stern M., Marek K., Friedman J., Hauser R., LeWitt P., Tarsy D., and Olanow W. Mov. Disord. 19 (2004) 916-923
10. Youdim M., Gross A., and Finberg J. Br. J. Pharmacol. 132 (2001) 500-506
11. Parkinson Study Group. Arch. Neurol. 59 (2002) 1937-1943
12. Parkinson Study Group. Arch. Neurol. 62 (2005) 241-248
13. Parkinson Study Group. Lancet 365 (2005) 947-954
14. Chen J., Swope D., and Dashtipour K. Clin. Ther. 29 (2007) 1825-1849
15. Langer R. J. Control. Release 16 (1991) 53-59
16. ArVca B., KaY H.S., Moghdam A., Akalan N., and HVncal A.A. Eur. J. Pharm. Sci. 8 (1999) 5-6
17. Tamargo R.J., and Brem H. Neurosurgery 2 (1992) 259-279
18. Thébault J., Guillaume M., and Levy R. Pharmacotherapy 24 (2004) 1295-1305
19. Finberg J., Lamensdorf I., Commissiong J., and Youdim M. J. Neural Transm. 48 (1996) 95-101
20. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Q2B: Guideline on Validation of Analytical Procedure-Methodology, London, November 1996.
21. Shabir G.A. J. Chromatogr. A 987 (2003) 57-66